Grupo Alfa (ALFAA) investor relations material

Executive summary

• Completed transformation to a pure-play packaged food business, with shares reclassified as Consumer Staples under GICS since April 2025 and the Alpek spin-off finalized.

• Achieved record quarterly revenues in 2Q25, strong operating momentum, and improved valuation and industry recognition.

• Corporate rebranding and ticker change preparations are underway, with an extraordinary shareholders meeting planned for approvals.

• Maintained consistent results amid global uncertainty, leveraging scale, diversification, and a multi-segment brand portfolio.

Financial highlights

• 2Q25 revenues reached US$2.297 billion, up 1% year-over-year, with currency-neutral growth of 7%.

• 2Q25 EBITDA was US$305 million, including US$77 million in non-recurring insurance gains; comparable EBITDA was US$246 million, down 10% year-over-year.

• Year-to-date EBITDA reached US$576 million, up 10% year-over-year, benefiting from US$110 million in non-recurring items.

• US achieved record quarterly volume and revenues, with EBITDA up 1% year-over-year.

• Europe’s Q2 EBITDA included a nonrecurring gain of €68M from insurance reimbursements for flood damages.

Outlook and guidance

• Year-to-date comparable EBITDA is on track with full-year guidance despite higher-than-expected protein input costs.

• Focused on sustaining positive sequential trends and meeting full-year guidance, despite ongoing raw material cost pressures.

• Ongoing recovery plan for Spanish production capacity, with new plant in Valencia expected fully operational by 2027.

• Expecting margin improvement in Mexico in H2 2025 if FX remains favorable and cost pressures are managed.

• Anticipate volume growth between flat and low single digits across regions in H2, depending on further pricing actions.